nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma
|
Liu, S.S |
|
2001 |
37 |
9 |
p. 1104-1110 7 p. |
artikel |
2 |
A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer
|
Westermann, A.M |
|
2001 |
37 |
9 |
p. 1111-1117 7 p. |
artikel |
3 |
A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma
|
Gortzak, E |
|
2001 |
37 |
9 |
p. 1096-1103 8 p. |
artikel |
4 |
Calendar of Forthcoming Meetings
|
|
|
2001 |
37 |
9 |
p. I-II nvt p. |
artikel |
5 |
Deriving a compound quality of life measure from the EORTC-QLQ-C30/LC13 instrument for use in economic evaluations of lung cancer clinical trials
|
Bagust, A |
|
2001 |
37 |
9 |
p. 1081-1088 8 p. |
artikel |
6 |
Different effects of methotrexate on DNA mismatch repair proficient and deficient cells
|
Frouin, I |
|
2001 |
37 |
9 |
p. 1173-1180 8 p. |
artikel |
7 |
Electrochemotherapy of tumours resistant to cisplatin
|
Cemazar, M |
|
2001 |
37 |
9 |
p. 1166-1172 7 p. |
artikel |
8 |
End of life care in patients with malignant disease
|
Stone, P |
|
2001 |
37 |
9 |
p. 1070-1075 6 p. |
artikel |
9 |
Erratum to ‘Cervical cancer screening in Austria’ Eur J Cancer 2000, 36, 2189–2190
|
Breitenecker, G |
|
2001 |
37 |
9 |
p. 1181- 1 p. |
artikel |
10 |
Erratum to ‘Tibolone actions on normal and breast cancer cells’ Eur J Cancer 2000, 36(Suppl. 4), S76–S77
|
Gompel, A |
|
2001 |
37 |
9 |
p. 1182- 1 p. |
artikel |
11 |
IARC links weight gain to cancers
|
|
|
2001 |
37 |
9 |
p. 1061-1065 5 p. |
artikel |
12 |
Incidence and prevalence of all cancerous diseases in Italy
|
Verdecchia, A |
|
2001 |
37 |
9 |
p. 1149-1157 9 p. |
artikel |
13 |
Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF
|
Schmoor, C |
|
2001 |
37 |
9 |
p. 1123-1131 9 p. |
artikel |
14 |
Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer
|
Kristiansen, G |
|
2001 |
37 |
9 |
p. 1089-1095 7 p. |
artikel |
15 |
Reduction in the local expression of complement component 6 (C6) and 7 (C7) mRNAs in oesophageal carcinoma
|
Oka, R |
|
2001 |
37 |
9 |
p. 1158-1165 8 p. |
artikel |
16 |
Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer
|
Namer, M |
|
2001 |
37 |
9 |
p. 1132-1140 9 p. |
artikel |
17 |
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers
|
Macmillan, R.D. |
|
2001 |
37 |
9 |
p. 1076-1080 5 p. |
artikel |
18 |
Studies on oestrogen receptor-α and -β mRNA in breast cancer
|
Cullen, R |
|
2001 |
37 |
9 |
p. 1118-1122 5 p. |
artikel |
19 |
Veno-occlusive disease with multi-organ involvement following actinomycin-D
|
D'Antiga, L |
|
2001 |
37 |
9 |
p. 1141-1148 8 p. |
artikel |
20 |
Why remove four by chance when one will suffice?
|
Hansen, N.M |
|
2001 |
37 |
9 |
p. 1067-1069 3 p. |
artikel |